Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

91
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
91
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

66
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
66
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

85
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
85
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

32
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
32
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

116
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
116

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ebastine mitigates cisplatin-induced pulmonary injury associated with alterations in the miR-101/PI3K/mTOR/ULK1 signaling axis.

Molecular biology reports·2026
Same author

Unprecedented novel 2-aryl-1-phenethyl-4,5-diphenyl-1H-imidazole compounds: Design, synthesis, toxicological activity, and biochemical studies.

Pest management science·2026
Same author

Functionalized Thiacalix[4]arenes as Dual Metal-Ion Extractants and Insecticidal Agents: Synthesis, Characterization, and Insecticidal Activity Against Spodoptera littoralis.

Chemistry & biodiversity·2026
Same author

Discovery and Evaluation of Spirofluorenes Based on Imidazolidinedione as Insecticidal Agent Leads.

Chemistry & biodiversity·2026
Same author

Identification of physiological races of Puccinia striiformis f. sp. tritici and molecular docking of some biological treatments as prospective fungal inhibitor candidates in wheat.

Scientific reports·2026
Same author

Synthesis, Photophysical Properties, and Biological Evaluation of New Thiazolo[3,2-<i>a</i>]pyrimidine Derivatives as Promising Insecticidal and Anti-inflammatory Agents.

Journal of agricultural and food chemistry·2026

Related Experiment Video

Updated: Sep 24, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.9K

Bile Cast Nephropathy: A Comprehensive Review.

Manoj R Somagutta1,2, Molly S Jain3,2, Maria Kezia Lourdes Pormento4,2

  • 1Department of Medicine and Research, Avalon University School of Medicine, Willemstad, CUW.

Cureus
|May 4, 2022
PubMed
Summary
This summary is machine-generated.

Bile cast nephropathy (BCN), a kidney injury linked to liver disease, involves circulation changes and tubular damage. Recent research highlights bile acids and bilirubin

Keywords:
acute kidney injurybile acidbile cast nephropathy and renal failurebilirubincholemic nephropathy

More Related Videos

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

7.8K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.7K

Related Experiment Videos

Last Updated: Sep 24, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.9K
A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

7.8K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.7K

Area of Science:

  • Nephrology
  • Hepatology
  • Internal Medicine

Background:

  • Bile cast nephropathy (BCN), also known as cholemic nephropathy (CN), is acute kidney injury (AKI) occurring alongside liver injury.
  • This condition is prevalent in liver disease patients, contributing to significant morbidity and mortality.
  • CN involves hemodynamic alterations, intratubular cast formation, and tubular epithelial cell injury, often overlooked in favor of hepatic concerns.

Purpose of the Study:

  • To review the evidence linking bile acids and bilirubin to acute renal dysfunction in liver injury.
  • To summarize the pathophysiology, risk factors, and therapeutic strategies for cholemic nephropathy.

Main Methods:

  • Systematic review of recent case reports and literature over the past two decades.
  • Analysis of pathophysiological mechanisms, including hemodynamic changes and cellular injury.
  • Evaluation of the role of specific biomarkers such as bile acids and bilirubin.

Main Results:

  • Evidence suggests a significant role for bile acids and bilirubin in the development of AKI in liver disease.
  • Pathophysiology involves complex interactions between hepatic dysfunction, systemic hemodynamics, and renal tubular damage.
  • Recent case reports have increased focus on CN as a critical differential diagnosis.

Conclusions:

  • Cholemic nephropathy is a critical complication of liver injury, driven by toxic bile components and hemodynamic disturbances.
  • Understanding the pathophysiology is key to identifying risk factors and developing targeted therapies.
  • Further research into therapeutic mechanisms and outcomes for CN is warranted.